漢瑞祥 HSIC 深 滬
等待開盤 10-24 09:30:00 美东时间
63.59
+0.080
+0.13%
華盛通- 最 高64.175
- 今 開63.27
- 成交量 156.02万股
- 最 低 63.08
- 昨 收 63.51
- 總市值 76.94亿
- 52周最高 82.49
- 市盈率 靜 20.83
- 換手率 1.29%
- 52周最低 60.56
- 委 比 96.14%
- 總股本 1.21亿
- 歷史最高 92.68
- 量 比 1.04
- 振 幅 1.72%
- 歷史最低 12.03
- 每 手 1
- 風險率 4.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Deep Dive Into Henry Schein Stock: Analyst Perspectives (8 Ratings)
Henry Schein (NASDAQ:HSIC) underwent analysis by 8 analysts in the last quarter...
10-23 05:01
临空区大兴片区已建成120万平方米产业载体，共引入市场主体8401家
▲10月20日，北京市人民政府新闻办公室举行“一把手发布·京华巡礼”系列主题新闻发布会——大兴·协同发展示范区 繁荣开放国门新城。大兴区政府主要负责同志带队介绍...
10-20 22:24
Biomerica Enters Marketing Partnership With Henry Schein To Promote Biomerica's Infoods Irritable Bowel Syndrome Test Across The United States, Excluding New York State
Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based
10-16 20:22
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
Biomerica partners with Henry Schein to expand marketing of its inFoods® IBS test, leveraging Henry Schein's national distribution network. The collaboration aims to accelerate adoption of Biomerica's non-drug, precision-based diagnostic therapy for IBS patients. Recent clinical studies published in *Gastroenterology* show the test significantly reduces symptoms, particularly in underserved IBS-M patients. Henry Schein's expertise and reach will ...
10-16 12:19
Peering Into Henry Schein Inc's Recent Short Interest
Henry Schein Inc's (NYSE:HSIC) short interest as a percent of float has risen 7...
10-03 01:00
2025年临空经济区可持续发展国际会议启幕
转自：新华财经 9月25日，2025年临空经济区可持续发展国际会议在大兴机场临空经济区开幕。现场，大兴机场临空经济区颁发首批一体化登记营业执照，三大合作平台启动...
09-26 15:11
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
SharkNinja's Obsession With Winning Drives Growth, Says Analyst
SharkNinja (NYSE: SN) focuses on growth through disruptive innovation and rigorous testing, with plans to expand into outdoor appliances and beauty.
09-24 03:17
Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analyst
Henry Schein sees steady dental market trends, with Piper Sandler expecting stronger equipment growth in the second half of 2025.
09-24 02:24
Barrington Research Maintains Outperform on Henry Schein, Maintains $78 Price Target
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and maintains $78 price target.
09-23 23:10
